Proton MR Spectroscopy In Multiple Sclerosis Abstracts - 01

  1. Prognostic value of high-field proton Magnetic Resonance Spectroscopy in patients presenting with Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    NeuroRadiology 2008 Feb;50(2):123-9

  2. Spinal Cord Spectroscopy and Diffusion-based Tractography to assess acute disability in Multiple Sclerosis
    Brain 2007 Aug;130(Pt 8):2220-31

  3. N-AcetylAspartic acid in CerebroSpinal Fluid of Multiple Sclerosis patients determined by gas-chromatography-mass Spectrometry
    J Neurol 2007 May;254(5):631-7

  4. Correlation of global N-Acetyl Aspartate with Cognitive Impairment in Multiple Sclerosis
    Arch Neurol 2006 Apr;63(4):533-6

  5. 1H-MRS quantification of tNA and tCr in patients with Multiple Sclerosis: a meta-analytic review
    Brain 2005 Nov;128(Pt 11):2483-506

  6. Magnetic Resonance Spectroscopy Of Normal-Appearing White Matter in early Relapsing/Remitting Multiple Sclerosis: correlations between disability and Spectroscopy
    BMC Neurol 2004 Jun 10;4(1):8

  7. Axonal injury in Multiple Sclerosis
    Curr Neurol NeuroSci Rep 2003 May;3(3):231-7

  8. Proton MR Spectroscopy with metabolite-nulling reveals elevated macromolecules in acute Multiple Sclerosis
    Brain 2001 May;124(Pt 5):953-61

  9. Proton Magnetic-Resonance Spectroscopy
    Zh Nevrol Psikhiatr Im S S Korsakova 2001;101(4):36-9

  10. Magnetic Resonance Spectroscopy in Multiple Sclerosis
    Rev Neurol (Paris) 2000 Dec;156(12):1078-1086

  11. Relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
    J Neurol NeuroSurg Psychiatry 2000 May;68(5):627-632

  12. Proton Magnetic Resonance Spectroscopy in Brain White Matter Disorders
    Ital J Neurol Sci 1997 Dec;18(6):331-9

  1. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome
    J Neurol 2008 Mar;255 Suppl 1:61-74

  2. Guidelines for using proton MR Spectroscopy in multicenter clinical MS studies
    Neurology 2007 Nov 13;69(20):1942-52

  3. Axonal Damage but no increased Glial Cell activity in the Normal-Appearing White Matter of patients with Clinically Isolated Syndromes suggestive of Multiple Sclerosis using high-field Magnetic Resonance Spectroscopy
    AJNR Am J NeuroRadiol 2007 Sep;28(8):1517-22

  4. MR Spectroscopy in Multiple Sclerosis
    J NeuroImaging 2007 Apr;17 Suppl 1:31S-35S

  5. Gray and Normal-Appearing White Matter in Multiple Sclerosis: an MRI perspective
    Expert Rev Neurother 2007 Mar;7(3):271-9

  6. Axonal loss is progressive and partly dissociated from Lesion Load in early Multiple Sclerosis
    Neurology 2007 Jul 3;69(1):63-7

  7. Can imaging techniques measure NeuroProtection and ReMyelination in Multiple Sclerosis?
    Neurology 2007 May 29;68(22 Suppl 3):S72-82; discussion S91-6

  8. Onset and underpinnings of White Matter Atrophy at the very early stage of Multiple Sclerosis--a two-year longitudinal MRI/MRSI study of Corpus Callosum
    Mult Scler 2007 Jan;13(1):41-51

  9. 1H MR Spectroscopy of the Brain in Multiple Sclerosis subtypes with analysis of the metabolite concentrations in Gray and White Matter: initial findings
    Eur Radiol 2006 Feb;16(2):489-95

  10. Multi-slice echo-planar Spectroscopic MR imaging provides both global and local metabolite measures in Multiple Sclerosis
    Magn Reson Med 2005 Apr;53(4):750-9

  11. Magnetic Resonance Spectroscopy and its clinical applications in Multiple Sclerosis
    Nippon Rinsho 2003 Aug;61(8):1435-41

  12. Proton MR Spectroscopic imaging in Multiple Sclerosis
    NeuroRadiology 2002 Jan;44(1):37-42

  13. Magnetic Resonance techniques to quantify tissue damage, tissue repair, and Functional Cortical reorganization in Multiple Sclerosis
    Prog Brain Res 2009;175:465-82